Hemolysis in Rodent Blood Sampling and Biomarker Validity - A Narrative Review
Acta VETERINARIA Indonesiana · 26.07.2026 · 14 (2) · 149-157
DOI: 10.29244/avi.14.2.149-157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta VETERINARIA Indonesiana, online erschienen am 26.07.2026. Verfasst von Athaya Nayla Pasca Rahman und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Background
Blood sampling is essential in rodent biomedical research, yet hemolysis, remains a major source of bias. Hemolysis is common, often underreported, and can significantly distort serum and plasma biomarker results, compromising reproducibility, translational validity, and adherence to 3Rs principles.
Aims
This narrative review synthesizes current evidence on mechanisms, technique-related risk patterns, biomarker interference, and prevention strategies for hemolysis in laboratory rodent blood sampling.
Methods
The literature was searched using PubMed, Scopus, and Google Scholar to identify publications published from 2000 onward that addressed hemolysis in rodent blood sampling: search terms combined hemolysis, blood collection techniques, and laboratory rodents. Experimental studies, methodological reports, guidelines, and relevant reviews were included when they examined pre-analytical factors affecting serum or plasma biomarkers. Findings were integrated qualitatively due to heterogeneity in study design, analytical endpoints, and hemolysis assessment approaches.
Results
Hemolysis risk varies by sampling technique and procedural handling, with peripheral serial methods generally more susceptible to mechanical stress than terminal approaches. Analytical impact is biomarker dependent, particularly for intracellular analytes. Objective hemolysis indices improve assessment consistency. Standardized collection, processing, and reporting practices are essential to enhance reproducibility and 3Rs alignment.
Conclusion
Hemolysis is a modifiable source of pre-analytical variability in rodent studies. Standardizing sampling procedures, implementing objective quality assessments, and ensuring transparent reporting can enhance biomarker validity while promoting methodological rigor and ethical compliance.
Zitieren
APA
Rahman, A. N. P., Maulana, H. V., Setyaningrum, D. A. W., & Hairunisa, N. (2026). Hemolysis in Rodent Blood Sampling and Biomarker Validity - A Narrative Review. Acta VETERINARIA Indonesiana, 14(2), 149-157. https://doi.org/10.29244/avi.14.2.149-157
Vancouver
Rahman ANP, Maulana HV, Setyaningrum DAW, Hairunisa N. Hemolysis in Rodent Blood Sampling and Biomarker Validity - A Narrative Review. Acta VETERINARIA Indonesiana. 2026;14(2):149-157. doi:10.29244/avi.14.2.149-157
BibTeX
@article{Rahman2026,
author = {Rahman, Athaya Nayla Pasca and Maulana, Hazel Veda and Setyaningrum, Dyah Ayu Woro and Hairunisa, Nany},
title = {Hemolysis in Rodent Blood Sampling and Biomarker Validity - A Narrative Review},
journal = {Acta VETERINARIA Indonesiana},
year = {2026},
volume = {14},
number = {2},
pages = {149--157},
doi = {10.29244/avi.14.2.149-157}
}
EUVIMED